MedTrace Logo

Aurolab Hydrophobic Foldable Intraocular Lens Study

NCT00449267 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2009-02-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether hydrophobic intraocular lenses manufactured by aurolab are safe and effective in the surgical treatment of cataract.

Conditions

  • Cataract

Interventions

DEVICE

Intraocular Lens

Phacoemulsification with in the bag implantation of the IOL

Sponsors & Collaborators

  • Aurolab

    lead OTHER

Principal Investigators

  • Haripriya Aravind, MBBS, MS · Aravind Eye Hospital, Madurai

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00449267 on ClinicalTrials.gov